期刊文献+

上海市胃肠道间质瘤的临床调查及预后分析 被引量:4

Gastrointestinal stromal tumors : epidemiological investigation and prognostic analysis in Shanghai
下载PDF
导出
摘要 目的 研究上海市疾病控制中心(CDC)从 2003年1月1日至2008年12月31日登记的713例胃肠道间质瘤(GIST)的临床流行病学特征和预后因素. 方法 用描述性统计和生存分析中的log-rank检验和Cox模型对资料进行分析. 结果 肿瘤原发灶部位主要分布在胃419例(58.8%)、小肠203例(28.5%)、大肠58例(8.1%),偶见于腹腔1例(0.14%).COX生存分析显示性别、年龄、肿瘤原发部位、肿瘤分期以及不同的手术方式均是影响GIST预的相关因素. 结论 GIST预后的影响因素复杂,应结合实际作综合考虑.本研究提示老龄患者、晚期患者,以及未接受外科手术也是影响GIST患者预后的重要因素.因此对于GIST患者还是应以早发现,并首选外科根治手术治疗为根本措施. Objective To investigate the clinical epidemiology characteristics and prognostic factors of 713 gastrointestinal stromal tumors (GIST) patients from Shanghai CDC's data bank for Shanghai tumor patient enrcgister during the period from January 1,2003 to December 31,2008. Methods Performed the descriptive statistics, log-rank test and Cox regression analysis. Results The tumor primary tumor site is mainly distributed in the stomach 419 cases ( 58.8% ) ; small bowel 203 cases (28.5%) : colorectal 58 patients (8.1%), occasionally in the abdominal cavity in 1 case (0.14%). COX survival analysis showed age, sex, primary tumor site, tumor stage and different surgical methods are the relevant factors affecting the pre-GIST. Conclusion GIST prognosis of complex factors, should be integrated with the practical considerations, this study suggests that older patients, the terminally ill, and did not receive surgery that affects an important factor in the prognosis of GIST patients, it should be for GIST patients is still early detection, and the preferred surgical treatment of radical surgery as the fundamental measures.
出处 《中国医院统计》 2010年第3期197-199,共3页 Chinese Journal of Hospital Statistics
基金 北京诺华制药有限公司资助项目
关键词 胃肠道间质瘤 流行病学调查 Gastrointestinal stromal tumor Epidemiologieal investigation
  • 相关文献

参考文献10

  • 1Fletcher CD,Beman JJ,Corless C,et al.Diangnosis of gastrointestinal stromal tumors:A consensus approach[J].Hum Pathol,2002,33(5):459-465.
  • 2Mazur MT,Clark HB.Gastric stromal tumors:Reappraisal of histoge nesis[J].Am J Surg Pathol,1983,7(6):507-519.
  • 3Derynck R,Jarrett JA,Chen EY,et al.Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells[J].Nature,1985,316(6030):701-705.
  • 4Nilsson B,Bumming P,Kindblom JM,et al.Gastrointestinal stromal tumors:the incidence,prevalence,clinical course,and prognostication in the preimatinib mesylate era--a population-based study in Western Sweden[J].Cancer,2005,103(4):821-829.
  • 5Bucher P,Egger JF,Gervaz P,et al.An audit of surgical management of gastrointestinal stromal tumours(GIST)[J].Eur J Surg Oncol,2006,32(3):310-314.
  • 6侯英勇,王坚,朱雄增,陶琨,陆孝禹,杜祥,孙孟红,郑爱华.食管间质瘤与平滑肌肿瘤对照性研究[J].中华病理学杂志,2002,31(2):116-119. 被引量:44
  • 7Reith JD,Goldblum JR,Lyles RH,et al.Extragastrointestinal (soft tissue) stromal tumors:an analysis of 48 cases with emphasis on histologic predictors of outcome[J].Mod Pathol,2000,13(5):577-585.
  • 8邵永孚,白月奎,曹文兰,石素胜,高燕宁,孙耘田,余力伟.腹内胃肠外间质瘤30例临床病理分析[J].中华胃肠外科杂志,2007,10(1):29-32. 被引量:13
  • 9Miettinen M,El-Rifai W,H L Sobin L,et al.Evaluation of malignancy and prognosis of gastrointestinal stromal tumors:a review[J].Hum Pathol,2002,33(5):478-483.
  • 10Singer S,Rubin BP,Lux ML,et al.Prognostic value of KIT mutation type,mitotic activity,and histologic subtype in gastrointestinal stromal tumors[J].J Clin Oncol,2002,20(18):3898-3905.

二级参考文献15

  • 1Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of hitogenesis. Am J Surg Pathol, 1983, 7: 507-519.
  • 2Suster S. Gastrointestinal stromal tumors. Semin Diagn Path ol, 1996, 13:297-313.
  • 3Kindblom LG,Remotti HE,Aldenborg F,et al. Gastrointestina l pacemaker cell t umor(GIPACT):gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol,1998,152:1259-1269.
  • 4Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Esophageal stromal tumors: a c linicopathologic, immunohistochemical, and molecular genetic study of 17 cases a nd comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol, 2000, 24:211-222.
  • 5Hatch GF 3rd,Wertheimer-Hatch L,Hatch KF, et al. Tumors o f the esophagus. World J Surg,2000,24:401-411.
  • 6Emory TS, Sobin LH, Lukes L,et al. Prognosis of gastrointes tinal smooth-muscl e (stromal) tumors: dependence on anatomic site. Am J Surg Pathol, 1999, 23:82 -87.
  • 7Miettinen M,Monihan J,Sarlomo-Rikala M,et al.Gastrointestinal stromal tumors/smooth muscle tumors primary in the omentum and mesentery.Clinicopathologic and immunohistochemical study of 26 cases.Am J Surg Pathol,1999,23:1109-1118.
  • 8eith JD,Goldblum JR,Lyles RH,et al.Extragastrointestinal (soft tissue) stromal tumors:an analysis of 48 cases with emphasis on histologic predictors of outcome.Med Pathol,2000,13:577-585.
  • 9Fletcher CD,Berman JJ,Corless C,et al.Diagnosis of gastrointestinal stromal tumors:A consensus approach.Hum Pathol,2002,33:459-465.
  • 10Hu X,Forster J,Damjanov I.Primary malignant gastrointestinal stromal tumor of the liver.Arch Pathol Lab Med,2003,127:1606-1608.

共引文献55

同被引文献27

  • 1梁小波,于红宾,王立平.胃肠道间质瘤的临床流行病学调查[J].肿瘤研究与临床,2006,18(8):505-507. 被引量:30
  • 2詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 3万德森,伍小军,潘志忠,周志伟,陈功,李力人,卢震海,丁培荣.甲磺酸伊马替尼治疗51例晚期胃肠道间质瘤患者的疗效分析[J].中华医学杂志,2006,86(43):3064-3067. 被引量:15
  • 4Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 2005; 100: 162-168 PubMed DOI.
  • 5Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465 PubMed DOI.
  • 6Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol 1983; 7: 507-519 PubMed DOI.
  • 7Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580 PubMed DOI.
  • 8Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-710 PubMed DOI.
  • 9Fusaroli P, Caletti G. Endoscopic ultrasonography: current clinical role. Eur J Gastroenterol Hepatol 2005; 17: 293-301 PubMed DOI.
  • 10Ji F, Wang ZW, Wang LJ, Ning JW, Xu GQ. Clinicopathological characteristics of gastrointestinal mesenchymal tumors and diagnostic value of endoscopic ultrasonography. J Gastroenterol Hepatol 2008; 23: e318-e324 PubMed DOI.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部